Israel Active

Muslim United Hatzalah EMTs Nour and Mohamed, had finished their pre-wedding photos when they saw an accident involving a young cyclist and a truck. Dressed in their wedding clothes, they didn’t hesitate to provide emergency medical treatment to the injured nine-year-old boy.

Scientists at Israel’s Technion Institute have succeeded in 3D printing a network of blood vessels that can provide blood to implanted tissues. The collagen used in the printing process was derived from tobacco plants and made by Israel’s Collplant.

Scientists at Tel Aviv University have enabled friendly bacteria to attack bad bacteria with toxins and neutralize them. They programmed safe bacteria to attack only specific pathogens, using the Type 6 Secretion system that germs use to destroy cells.

United Hatzalah CEO Eli Beer gives another of his straight-forward step-by-step guides – this time to CPR which could save a life if an EMT failed to arrive in the 3 minutes that United Hatzalah target.

The Israel Cancer Research Fund (ICRF) has announced 74 new cancer research grants valued at over $4.6 million, that will be funded in 2021/22.

Israel’s MeMed Diagnostics (see previously) has received US FDA clearance for its MeMed BV blood test that can distinguish, in minutes, between bacterial and viral infections. It can help prevent the inappropriate use of antibiotics that leads to antimicrobial resistance (AMR).

Useful webinar on coronavirus mutations and the booster shots from two leading Ben Gurion University experts - Prof. Nadav Davidovitch, M.D., Ph.D., M.P.H., and Dr. Anat Rosenthal, Ph.D.

Doctors and nurses currently serving in the IDF have commenced the “Hand-in-hand” initiative. Coronavirus patients are transferred from hospital to home-based care. They are monitored remotely from a command center, with at least once-a-day on-site visits from medical personnel.

Israeli-managed Code Pharma developed its Codivir treatment for HIV at its Israeli R&D center. It has just completed a successful Phase 1 trial in Brazil for using Codivir against the coronavirus and has applied to start a Phase 2 trial on 150 patients in Israel, Spain, Brazil and South Africa.

The Chair of UK’s Health and Social Care Select Committee, MP Jeremy Hunt, stated in Parliament that Israel shows that a booster program reduces Covid hospitalizations in just two weeks. Israeli research also shows that the booster gives 10 times more antibodies than the second jab.